Mode
Text Size
Log in / Sign up
N/A N=1,529

Advance Cardiac Resynchronization Therapy (CRT) Registry

Heart Failure

Enrolled (actual)
1,529
Serious AEs
14.8%
Results posted
Aug 2019
Primary outcome: Primary: Number of CRT Non-responders Using 1) Clinical Composite Score (CCS) and 2) Site-specific Criteria for Determining CRT Response — 1061; 900 Participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
CRT Patients (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Abbott Medical Devices
Primary completion
Nov 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of CRT Non-responders Using 1) Clinical Composite Score (CCS) and 2) Site-specific Criteria for Determining CRT Response
1061; 900
PRIMARY
Number of Subjects With Specfic Types of Symptom-based and Objective Definitions Used by Sites to Determine Patients' Response to CRT
431; 847; 858
PRIMARY
Number of Subjects That Received Treatment Strategies for Heart Failure in the CRT Non-responder Population Between 6 and 12 Months
63; 197; 88; 319; 79; 53
PRIMARY
Number of Subjects Who Had an Improvement in NYHA Class Between Six Months and 12 Months
93; 34

Summary

The intent of this registry is to understand comprehensive clinical care strategies for Cardiac Resynchronization Therapy (CRT) patients especially non-responders in real-world clinical practice.

Eligibility Criteria

Inclusion Criteria

  • Patient willing and able to sign informed consent
  • Patients implanted with any market-approved St. Jude Medical CRT-D/P device with no prior LV lead placement

Exclusion Criteria

  • Are likely to undergo heart transplantation within the next 12 months
  • Are less than 18 years of age
  • Are pregnant or planning to become pregnant during the duration of the study
  • Are currently participating in a clinical investigation that includes an active treatment arm
  • Have a life expectancy of less than 6 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01805154). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search